PrEP in China: choices are ahead

Lancet HIV. 2020 Mar;7(3):e155-e157. doi: 10.1016/S2352-3018(19)30293-0. Epub 2019 Aug 28.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / administration & dosage
  • China / epidemiology
  • Female
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • Homosexuality, Male / statistics & numerical data
  • Humans
  • Male
  • Pre-Exposure Prophylaxis*
  • Tenofovir / administration & dosage

Substances

  • Anti-HIV Agents
  • Tenofovir